Critical Limb Ischemia clinical trials

Explore recruiting critical limb ischemia clinical trials.

Recruiting critical limb ischemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Critical Limb Ischemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Augmenting ischemia-induced vasculo- and angiogenesis after endovascular reperfusion with host-extracted, percutaneously introduced, leucocyte- and platelet-rich fibrin in patients with critical limb ischemia

Poland

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Tolerance study of allogeneic of Adipose tissue derived mesenchymal Stroma/stem Cells (AdMSC) transplantation in patients with critical limb ischemia

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase 1/2, Open label & double-blind randomized placebo-controlled study to assess the feasibility of BGC101 (EnEPC) in the treatment of peripheral arterial disease (PAD) with critical limb ischemia (CLI)

Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Critical Limb Ischemia trials by city

Critical Limb Ischemia in Toronto Critical Limb Ischemia in Vancouver Critical Limb Ischemia in Montreal Critical Limb Ischemia in Calgary Critical Limb Ischemia in Edmonton Critical Limb Ischemia in Ottawa Critical Limb Ischemia in Winnipeg Critical Limb Ischemia in Quebec City Critical Limb Ischemia in Hamilton Critical Limb Ischemia in Kitchener Critical Limb Ischemia in London Critical Limb Ischemia in Halifax Critical Limb Ischemia in New York Critical Limb Ischemia in Los Angeles Critical Limb Ischemia in Chicago Critical Limb Ischemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease